American College of Cardiology

The mSToPS trial revealed a wearable ECG patch can markedly increase the AFib diagnosis rate relative to routine care—as much as 9-fold in the short-term and 3-fold in the long-term.

MOMENTUM 3 found that advanced heart-failure patients with an implanted centrifugal-flow circulatory pump had lower rates of pump-related blood clots and stroke.

Studies reveal short- and long-term effects of heart changes in college and professional football players.

The use of instantaneous wave-free ratio can reportedly save each patient at least $800 in comparison with fractional flow reserve.

While full parity may be impossible, a 4-step protocol did decrease discrepancies in clinical outcomes and mortality between men and women.

Clinicians have been shown to be influenced by their patients’ genetic makeup when prescribing antiplatelet therapies.

All-cause mortality and death due to stroke, however, were 1.8% and 0.5% lower, respectively, in the group utilizing WCD.

Study sheds new light on potential risks and benefits of aspirin for people with both conditions.

The trial showed alirocumab reduced MACE by 24% with an ARR of 3.4% and all-cause death by 29% with an ARR of 1.7% in patients with ACS and baseline LDL-C ≥100 mg/dL.

Using the database from the 40-country, double-blind phase 3 ARISTOTLE study, which has been around for over 5 years, a sub-analysis was conducted by Renato Lopes, MD, PhD, professor of Medicine at Duke University in Durham, North Carolina and colleagues.

Microbleeds in the brain appear to increase with cardiac procedures:Study.

The Absorb GT1 Bioresorbable Vascular Stent raised concerns at the FDA.

Excitement has been surrounding PCSK9 inhibitors due to high efficacy in lowering cholesterol. However, two reports in 2015 found that two of these drugs (evolocumab and alirocumab) were linked to cognitive issues. A phase 3 trial at ACC 2017 set out to find if that's actually the case.

Drugs were as effective in CTO patients as PCI, Korean study found.

New diagnostic tool iFR is less painful for heart patients than FFR.

In another major study comparing TAVR to surgery, outcomes were similar.

Even as technology improves to help patients dealing with cardiovascular disease, those responsible for the procedures also must consider providing treatment while weighing the costs of that work.

As doctors have more tools to treat patients with high cholesterol the American College of Cardiology released a new consensus statement to give guidance on potential best practices for non-statin therapies like PCSK9 inhibitors.

At the 2015 meeting of the American College of Cardiology PCSK9 inhibitors like Praluent were moving closer to approval but were not there yet. Since then they have been approved and begun to be introduced to the public.

The American College of Cardiology's outgoing President Kim A. Williams, MD, went vegan in 2003 and never looked back. He talks about the diet's power to heal and how being the ACC's first vegan leader played out.

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

For those how enter the field of genetic testing there are many challenges along the way, starting with finding the right training program through using that training in very difficult situations.

Hopes that losmapimod would benefit patients after a STEMI heart attack were not borne out by a study reported today at the American College of Cardiology's meeting in Chicago, IL.

Treating atrial fibrillation by ablation is equally effective whether done by freezing or burning small parts of the heart.

A newer version of a valve system used in transcatheter aortic valve replacement has proved superior to surgery in elderly patients. The study was released a day after a report on the older device showed it was as good as surgery.

Trans Aortic Valve Replacement, a less invasive procedure than open heart surgery, offers about the same benefits but slightly different risks, researchers reported today.

Despite corrective surgery known as the Fontan procedure, children who need that procedure have ongoing deficits.

Microcalcifications that can show up on mammograms can also predict a woman's risk of heart disease. MD Magazine spoke to Khurram Nasir, MD, co-author of an editorial urging physicians and their specialty societies to put this finding into practice.

Physicians may think patients over 80 are too old to benefit from agressive care to treat unstable angina or clogged arteries that caused a heart attack. Think again, a Norwegian researcher said at the American College of Cardiology meeting in San Diego, CA. These patients were 47% more likely to survive and healthier after invasive procedures than a group that got non-invasive care.

Having worked at Cedars Sinai since 1982 Robert J. Siegel, MD, has seen a lot of changes in the medical profession and helped many doctors hone their craft as they begin their own work in the field.